India's Serum institute to sell AstraZeneca vaccine to private hospitals at $8/dose

April 21, 2021 3:41 AM EDT

FILE PHOTO: Officials unload boxes containing vials of AstraZeneca's COVISHIELD, a coronavirus disease (COVID-19) vaccine manufactured by Serum Institute of India, outside a vaccination storage centre in Ahmedabad, India, January 12, 2021. REUTERS/Amit D


News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

NEW DELHI (Reuters) - The Serum Institute of India said on Wednesday it would sell the AstraZeneca vaccine to the country's state governments at 400 rupees ($5.30) per dose and to private hospitals at 600 rupees ($7.95).

"Furthermore, owing to the complexity, and urgency of the situation it is challenging to supply it independently to each corporate entity," it said in a statement. "We would urge all corporate and private individuals to access the vaccines through the state facilitated machinery and private health systems."

($1 = 75.4620 Indian rupees)

(Reporting by Krishna N. Das and Euan Rocha, editing by Louise Heavens)



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Reuters